Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol? Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol? · Investor's Business Daily ALLISON GATLIN Mon, Mar 31, 2025, 2:18 PM 4 min read In This Article: NAMS NAMSW AZN AZNCF MRK AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. But AstraZeneca stock fell in line with pharma stocks. Continue Reading View Comments Terms and Privacy Policy Your Privacy Choices Utah Privacy Notice More Info Recommended Stories